Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression, remodels extracellular matrix and sensitizes to anti-PD1 therapy
Pancreatic ductal adenocarcinoma (PDAC) is considered to be a highly immunosuppressive
and heterogenous neoplasm which has extremely poor survival. Despite improved …
and heterogenous neoplasm which has extremely poor survival. Despite improved …
[PDF][PDF] Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression, remodels extracellular matrix and sensitizes to anti-PD1 therapy.
NS Sharma, VK Gupta, VT Garrido, R Hadad… - scholar.archive.org
Pancreatic ductal adenocarcinoma (PDAC) is considered to be a highly immunosuppressive
and heterogenous neoplasm which has extremely poor survival. Despite improved …
and heterogenous neoplasm which has extremely poor survival. Despite improved …
[引用][C] Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression, remodels extracellular matrix and sensitizes to anti-PD1 therapy
N Sharma, VK Gupta, V Garrido… - … : official journal of …, 2019 - scholarship.miami.edu